Moreover, the launch of iStent infinite has boosted the U.S. glaucoma franchise. The recent approval for iDose TR, a revolutionary micro-invasive, injectable therapy for glaucoma, will likely ...

Glaucoma, a leading cause of irreversible blindness, represents a significant challenge in ophthalmology. This review examines recent advancements in glaucoma treatment, focusing on innovative ...